Targeting lineage-specific heterogeneity and hypovascular-fibrotic barriers may enable precision immunotherapy in pituitary neuroendocrine tumors. - Song J; Li L; Ding L; Yang F; Mao H; Wang K; Li Q (Frontiers in immunology, 2026)